Maureen Newman is a researcher by trade, and brings her knowledge of the lab to BioNews Texas. Currently, she is serving as a PhD student at University of Rochester, and working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit’s laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment. She is a senior science and research columnist for BioNews Texas.
Health centers must report all cases of hepatitis C to federal officials, but a study suggests that all but one case of hepatitis C went unreported in Massachusetts in a ... Read more
A study of over 3,000 eligible subjects in the Electronically Retrieved Cohort of Hepatitis C Viral (HCV) Infected Veterans (ERCHIVES) identified that statin use may be beneficial to sustained virologic ... Read more
With a long liver transplant wait list for patients with hepatocellular carcinoma due to hepatitis B virus, clinicians are keen to find alternative methods of treating their patients. For some ... Read more
Despite the hope generated by more efficacious, safer hepatitis C drugs within the past years, a number of patients with the chronic liver disease may not qualify for access to ... Read more
